CRI
UTHR icon

Colonial River Investments’s United Therapeutics UTHR Stock Holding History

Colonial River Investments’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,367
Closed -$482K – 259
2024
Q4 		$482K Buy
1,367
+154
+13% +$56.6K 0.23% 101
2024
Q3 		$435K Buy
+1,213
New +$410K 0.22% 105

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Colonial River Investments's UTHR Position: Q1 2025 in Review

Colonial River Investments sold out of United Therapeutics (UTHR) in Q1 2025, closing a stake of 1,367 shares — an estimated $482K sold.

Colonial River Investments first reported a position in UTHR in Q3 2024 and held it in 2 quarters. The position peaked at $482K in Q4 2024. 671 funds tracked by Wall St. Rank hold UTHR as of Q1 2025.

  • Colonial River Investments reported no remaining United Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Colonial River Investments sold 1,367 United Therapeutics shares in Q1 2025, an estimated $482K.
  • Colonial River Investments first reported a position in United Therapeutics in Q3 2024 and held it in 2 quarters.
  • Colonial River Investments's United Therapeutics position peaked at $482K in Q4 2024.
  • 671 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2025.

Based on Colonial River Investments's 13F filing for Q1 2025, filed 25 Apr 2025.